Is a complete GMAB research report available?

No complete published report is available for Genmab A/S (GMAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Genmab A/S (GMAB)

NASDAQ: GMAB · USD

$57.5

+12.78 (+28.6%)· Recorded snapshot

Market cap	34.3B
Revenue (ttm)	4.1B
Net income (ttm)	788M
EPS (ttm)	$1.23
Shares out	59.7M
P/E (trailing)	46.6x
P/E (forward)	38.9x
Volume	28,520,148
Beta	0.65

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001434265
Company name	Genmab A/S
Country	Denmark
Country code	US
CUSIP number	372303206
Earnings date	2026-11-05
Employees	3,119
Employees change	480
Employees growth	18.19%
Enterprise value	$38B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
Industry	Biotechnology
Is primary listing	No
Is SPAC	No
ISIN number	US3723032062
Last 10-K release date	2026-02-17
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2018-05-01
Last stock split type	Forward
Market cap	$34.3B
Market cap category	Large-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$57.45
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GMAB
Website	https://www.genmab.com

Metric

Value

Amount currency

USD

CIK code

0001434265

Company name

Genmab A/S

Country

Denmark

Country code

CUSIP number

372303206

Earnings date

2026-11-05

Employees

3,119

Employees change

480

Employees growth

18.19%

Enterprise value

$38B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1999

Industry

Biotechnology

Is primary listing

Is SPAC

ISIN number

US3723032062

Last 10-K release date

2026-02-17

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2018-05-01

Last stock split type

Forward

Market cap

$34.3B

Market cap category

Large-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$57.45

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GMAB

Website

https://www.genmab.com

Metric	Value
Adjusted P/E ratio	37x
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	20.4x
Average P/E ratio (5Y)	30.26x
Earnings yield	2.15%
EV/Earnings	38.54x
EV/EBIT	22.77x
EV/EBITDA	22.05x
EV/FCF	34.95x
EV/Sales	7.35x
FCF / EV yield	2.86%
FCF yield	3.25%
Forward EV/Sales	5.85x
Forward P/E	38.89x
Forward P/S	5.14x
Graham number	20.98691
Graham upside	-61.51%
Lynch fair value	$23.31
Lynch upside	-57.25%
P/(FCF - SBC) ratio	37.44x
P/(OCF - SBC) ratio	36.32x
P/B ratio	4.48x
P/E ratio	46.58x
P/FCF ratio	30.72x
P/OCF ratio	29.96x
P/S ratio	6.46x
Price/EBITDA ratio	19.39x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

37x

Average P/E ratio (10Y)

41.3x

Average P/E ratio (3Y)

20.4x

Average P/E ratio (5Y)

30.26x

Earnings yield

2.15%

EV/Earnings

38.54x

EV/EBIT

22.77x

EV/EBITDA

22.05x

EV/FCF

34.95x

EV/Sales

7.35x

FCF / EV yield

2.86%

FCF yield

3.25%

Forward EV/Sales

5.85x

Forward P/E

38.89x

Forward P/S

5.14x

Graham number

20.98691

Graham upside

-61.51%

Lynch fair value

$23.31

Lynch upside

-57.25%

P/(FCF - SBC) ratio

37.44x

P/(OCF - SBC) ratio

36.32x

P/B ratio

4.48x

P/E ratio

46.58x

P/FCF ratio

30.72x

P/OCF ratio

29.96x

P/S ratio

6.46x

Price/EBITDA ratio

19.39x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	32.29%
EBITDA margin	33.33%
Effective tax rate	13.02%
FCF margin	21.04%
Gross margin	93.03%
Operating margin	32.29%
Pretax margin	21.93%
Profit margin	19.08%
Profit per employee	$252,645
Profitable quarters	34
Profitable years	9
Revenue per employee	$1.3M
ROA	8.79%
ROA (5Y)	10.27%
ROCE	11.73%
ROE	14%
ROE (5Y)	18.28%
ROIC	12.07%
ROIC (5Y)	66.47%
SBC / revenue	3.78%
Tax / revenue	2.86%

Metric

Value

EBIT margin

32.29%

EBITDA margin

33.33%

Effective tax rate

13.02%

FCF margin

21.04%

Gross margin

93.03%

Operating margin

32.29%

Pretax margin

21.93%

Profit margin

19.08%

Profit per employee

$252,645

Profitable quarters

Profitable years

Revenue per employee

$1.3M

ROA

8.79%

ROA (5Y)

10.27%

ROCE

11.73%

ROE

14%

ROE (5Y)

18.28%

ROIC

12.07%

ROIC (5Y)

66.47%

SBC / revenue

3.78%

Tax / revenue

2.86%

Metric	Value
EPS growth	-36.79%
EPS growth (Q)	-9.41%
EPS growth (QoQ)	491.57%
EPS growth 10Y	22.48%
EPS growth 3Y	7.05%
EPS growth 5Y	15.83%
EPS growth years	0
FCF growth	-12.75%
FCF growth (Q)	-5.77%
FCF growth 3Y	1.65%
FCF growth 5Y	-0.57%
Gross profit growth	20.39%
Gross profit growth (Q)	23.39%
Gross profit growth 3Y	17.39%
Gross profit growth 5Y	26.91%
Net income growth	-37.9%
Net income growth (Q)	-9.82%
Net income growth (QoQ)	471.7%
Net income growth 3Y	5.02%
Net income growth 5Y	14.48%
Net income growth years	0
OCF growth	-14.08%
OCF growth (Q)	-17.74%
OCF growth (QoQ)	1,600%
OCF growth 10Y	26.01%
OCF growth 3Y	0.23%
OCF growth 5Y	-0.81%
Operating income growth	13.53%
Operating income growth (Q)	13.06%
Operating income growth 3Y	12.28%
Operating income growth 5Y	22.07%
Revenue growth	22.26%
Revenue growth (Q)	24.87%
Revenue growth (QoQ)	28.91%
Revenue growth 10Y	35%
Revenue growth 3Y	20.2%
Revenue growth 5Y	28.76%
Revenue growth quarters	20
Revenue growth years	4

Metric

Value

EPS growth

-36.79%

EPS growth (Q)

-9.41%

EPS growth (QoQ)

491.57%

EPS growth 10Y

22.48%

EPS growth 3Y

7.05%

EPS growth 5Y

15.83%

EPS growth years

FCF growth

-12.75%

FCF growth (Q)

-5.77%

FCF growth 3Y

1.65%

FCF growth 5Y

-0.57%

Gross profit growth

20.39%

Gross profit growth (Q)

23.39%

Gross profit growth 3Y

17.39%

Gross profit growth 5Y

26.91%

Net income growth

-37.9%

Net income growth (Q)

-9.82%

Net income growth (QoQ)

471.7%

Net income growth 3Y

5.02%

Net income growth 5Y

14.48%

Net income growth years

OCF growth

-14.08%

OCF growth (Q)

-17.74%

OCF growth (QoQ)

1,600%

OCF growth 10Y

26.01%

OCF growth 3Y

0.23%

OCF growth 5Y

-0.81%

Operating income growth

13.53%

Operating income growth (Q)

13.06%

Operating income growth 3Y

12.28%

Operating income growth 5Y

22.07%

Revenue growth

22.26%

Revenue growth (Q)

24.87%

Revenue growth (QoQ)

28.91%

Revenue growth 10Y

35%

Revenue growth 3Y

20.2%

Revenue growth 5Y

28.76%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-22M
Depreciation and amortization	$43M
EBIT	$1.3B
EBITDA	$1.4B
EPS	$1.23
FCF per share	$14.56
Financing cash flow	$5B
Free cash flow	$869M
Free cash flow minus SBC	$713M
Gross profit	$3.8B
Income taxes	$118M
Investing cash flow	$-5.6B
Net borrowing	$5.4B
Net cash flow	$207M
Net income	$788M
Operating cash flow minus SBC	$735M
Operating income	$1.3B
Revenue	$4.1B
Stock-based compensation	$156M

Metric

Value

Capital expenditures

$-22M

Depreciation and amortization

$43M

EBIT

$1.3B

EBITDA

$1.4B

EPS

$1.23

FCF per share

$14.56

Financing cash flow

$5B

Free cash flow

$869M

Free cash flow minus SBC

$713M

Gross profit

$3.8B

Income taxes

$118M

Investing cash flow

$-5.6B

Net borrowing

$5.4B

Net cash flow

$207M

Net income

$788M

Operating cash flow minus SBC

$735M

Operating income

$1.3B

Revenue

$4.1B

Stock-based compensation

$156M

Metric	Value
Altman Z-Score	2.91
Book value per share	$99.78
Debt / EBITDA	3.78
Debt / equity	0.89
Debt / FCF	6.07
Goodwill	$355M
Interest coverage	4.96
Long-term assets	$9.7B
Long-term liabilities	$5.4B
Net cash (debt)	$-3.8B
Net cash / market cap	-14.09%
Net debt / EBITDA	2.73
Net debt / equity	0.63
Net debt / FCF	4.33
Piotroski F-Score	4
Property, plant and equipment	$254M
Shareholders' equity	$6B
Tangible book value	$-3.3B
Tangible book value per share	$-54.77
Total assets	$12.5B
Total cash	$1.5B
Total debt	$5.3B
Total liabilities	$6.6B
WACC	7.24%

Metric

Value

Altman Z-Score

2.91

Book value per share

$99.78

Debt / EBITDA

3.78

Debt / equity

0.89

Debt / FCF

6.07

Goodwill

$355M

Interest coverage

4.96

Long-term assets

$9.7B

Long-term liabilities

$5.4B

Net cash (debt)

$-3.8B

Net cash / market cap

-14.09%

Net debt / EBITDA

2.73

Net debt / equity

0.63

Net debt / FCF

4.33

Piotroski F-Score

Property, plant and equipment

$254M

Shareholders' equity

$6B

Tangible book value

$-3.3B

Tangible book value per share

$-54.77

Total assets

$12.5B

Total cash

$1.5B

Total debt

$5.3B

Total liabilities

$6.6B

WACC

7.24%

Metric	Value
Asset turnover	0.44
Current assets	$2.8B
Current liabilities	$1.1B
Current ratio	2.46
Inventory turnover	18.58
Net working capital	$463M
Quick ratio	2.44
Working capital	$1.7B
Working capital turnover	1.67

Metric

Value

Asset turnover

0.44

Current assets

$2.8B

Current liabilities

$1.1B

Current ratio

2.46

Inventory turnover

18.58

Net working capital

$463M

Quick ratio

2.44

Working capital

$1.7B

Working capital turnover

1.67

Metric	Value
Buyback yield / dilution	1.73%
Dividend yield	0%
Shareholder yield	1.73%

Metric

Value

Buyback yield / dilution

1.73%

Dividend yield

Shareholder yield

1.73%

Metric	Value
10Y price change	242.14%
10Y return CAGR	13.09%
10Y total return	242.14%
150-day SMA	$30.44
1D price change	28.61%
1M price change	62.74%
1M total return	62.74%
1W price change	47.12%
1W total return	47.12%
1Y price change	98%
1Y return CAGR	98.1%
1Y total return	98%
20-day SMA	$39.44
200-day SMA	$30.28
3M price change	99.58%
3M total return	99.58%
3Y price change	102.25%
3Y return CAGR	26.46%
3Y total return	102.25%
50-day SMA	$36.20
50-day SMA vs 200-day SMA	50over200
52-week high	$59.97
52-week high date	2026-10-28
52-week low	$23.62
52-week low date	2026-06-03
5Y price change	27.17%
5Y return CAGR	4.93%
5Y total return	27.17%
6M price change	115.77%
6M total return	115.77%
All-time high	$59.97
All-time high date	2026-10-28
All-time low	$2.80
All-time low date	2013-06-24
Average true range (ATR)	$2.44
Average volume	6.2M
Beta (5Y)	0.65
Change from 52-week high	-4.2%
Change from 52-week low	143.23%
Change from all-time high	-4.15%
Change from all-time low	1,951.39%
Change from open	28.73%
Day's gap	-0.09%
Dollar volume	$1.6B
High price	$59.96
Low price	$44.43
Monthly RSI	79.04
Open price	$44.63
Position in 52-week range	83.84%
Premarket change	-0.02%
Premarket close	$44.67
Premarket price	$44.66
Premarket volume	5.5K
Previous close	$44.67
Price vs 150-day SMA	88.85%
Price vs 20-day SMA	45.75%
Price vs 200-day SMA	89.81%
Price vs 50-day SMA	58.78%
Relative volume	4.58
RSI	90.5
Sharpe ratio	1.64
Sharpe ratio (3Y)	0.66
Sharpe ratio (5Y)	0.19
Sortino ratio	3.55
Sortino ratio (3Y)	1.22
Sortino ratio (5Y)	0.46
Volume	28.5M
Weekly RSI	89.3
YTD price change	86.62%
YTD total return	86.62%

Metric

Value

10Y price change

242.14%

10Y return CAGR

13.09%

10Y total return

242.14%

150-day SMA

$30.44

1D price change

28.61%

1M price change

62.74%

1M total return

62.74%

1W price change

47.12%

1W total return

47.12%

1Y price change

98%

1Y return CAGR

98.1%

1Y total return

98%

20-day SMA

$39.44

200-day SMA

$30.28

3M price change

99.58%

3M total return

99.58%

3Y price change

102.25%

3Y return CAGR

26.46%

3Y total return

102.25%

50-day SMA

$36.20

50-day SMA vs 200-day SMA

50over200

52-week high

$59.97

52-week high date

2026-10-28

52-week low

$23.62

52-week low date

2026-06-03

5Y price change

27.17%

5Y return CAGR

4.93%

5Y total return

27.17%

6M price change

115.77%

6M total return

115.77%

All-time high

$59.97

All-time high date

2026-10-28

All-time low

$2.80

All-time low date

2013-06-24

Average true range (ATR)

$2.44

Average volume

6.2M

Beta (5Y)

0.65

Change from 52-week high

-4.2%

Change from 52-week low

143.23%

Change from all-time high

-4.15%

Change from all-time low

1,951.39%

Change from open

28.73%

Day's gap

-0.09%

Dollar volume

$1.6B

High price

$59.96

Low price

$44.43

Monthly RSI

79.04

Open price

$44.63

Position in 52-week range

83.84%

Premarket change

-0.02%

Premarket close

$44.67

Premarket price

$44.66

Premarket volume

5.5K

Previous close

$44.67

Price vs 150-day SMA

88.85%

Price vs 20-day SMA

45.75%

Price vs 200-day SMA

89.81%

Price vs 50-day SMA

58.78%

Relative volume

4.58

RSI

90.5

Sharpe ratio

1.64

Sharpe ratio (3Y)

0.66

Sharpe ratio (5Y)

0.19

Sortino ratio

3.55

Sortino ratio (3Y)

1.22

Sortino ratio (5Y)

0.46

Volume

28.5M

Weekly RSI

89.3

YTD price change

86.62%

YTD total return

86.62%

Metric	Value
Float	55.3M
Float percentage	92.69%
Shares change (QoQ)	-3.36%
Shares change (YoY)	-1.73%
Shares held by insiders	1.21%
Shares held by institutions	62.62%
Shares outstanding	59.7M
Short % of shares	1%
Short ratio	2.7 days

Metric

Value

Float

55.3M

Float percentage

92.69%

Shares change (QoQ)

-3.36%

Shares change (YoY)

-1.73%

Shares held by insiders

1.21%

Shares held by institutions

62.62%

Shares outstanding

59.7M

Short % of shares

Short ratio

2.7 days

Metric	Value
Page views	740

Metric

Value

Page views

740

Genmab A/S (GMAB)

Price

Financial snapshot

Fair-value bridge

Latest news · GMAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GMAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on GMAB

Frequently asked questions